JO3358B1 - معالجات حساسية العيون - Google Patents
معالجات حساسية العيونInfo
- Publication number
- JO3358B1 JO3358B1 JOP/2007/0103A JOP20070103A JO3358B1 JO 3358 B1 JO3358 B1 JO 3358B1 JO P20070103 A JOP20070103 A JO P20070103A JO 3358 B1 JO3358 B1 JO 3358B1
- Authority
- JO
- Jordan
- Prior art keywords
- ocular allergy
- allergy treatments
- treatments
- ocular
- alcaftadine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
يتعلق الاختراع بتركيبات (Compositions)، مجموعات (Kits) وطرق (methods) لعلاج او منع حساسية والتهاب العين واعراضها تشمل الكافتادين (alcaftadine) او ملح مقبول دوائيا منه.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78818506P | 2006-03-31 | 2006-03-31 | |
US68801607A | 2007-03-19 | 2007-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3358B1 true JO3358B1 (ar) | 2019-03-13 |
Family
ID=38468943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2007/0103A JO3358B1 (ar) | 2006-03-31 | 2007-04-01 | معالجات حساسية العيون |
Country Status (30)
Country | Link |
---|---|
US (7) | US8664215B2 (ar) |
EP (2) | EP2004196B1 (ar) |
JP (3) | JP5292277B2 (ar) |
KR (1) | KR101321731B1 (ar) |
CN (1) | CN102895234A (ar) |
AR (1) | AR060278A1 (ar) |
AU (1) | AU2007234957B2 (ar) |
BR (1) | BRPI0710085B8 (ar) |
CA (1) | CA2648115C (ar) |
CL (1) | CL2007000916A1 (ar) |
CR (1) | CR10414A (ar) |
DK (2) | DK2004196T3 (ar) |
EA (1) | EA016221B1 (ar) |
EC (1) | ECSP088786A (ar) |
ES (2) | ES2752823T3 (ar) |
HK (1) | HK1131331A1 (ar) |
IL (1) | IL194473A (ar) |
JO (1) | JO3358B1 (ar) |
MX (1) | MX2008012657A (ar) |
MY (1) | MY153669A (ar) |
NI (1) | NI200800261A (ar) |
NO (1) | NO341147B1 (ar) |
NZ (1) | NZ571690A (ar) |
PE (1) | PE20080053A1 (ar) |
PL (2) | PL3150209T3 (ar) |
SG (1) | SG170044A1 (ar) |
TW (2) | TWI450721B (ar) |
UY (1) | UY30254A1 (ar) |
WO (1) | WO2007117971A2 (ar) |
ZA (1) | ZA200809327B (ar) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2648115C (en) | 2006-03-31 | 2015-03-24 | Vistakon Pharmaceuticals, Llc | Ocular allergy treatments |
EP2015733A2 (en) | 2006-04-26 | 2009-01-21 | Aciex, Inc. | Compositions for the treatment and prevention of eyelid swelling |
CN101977595A (zh) * | 2007-11-08 | 2011-02-16 | 阿西克斯医疗公司 | 用于治疗以及预防眼睑肿胀的组合物 |
EP3943069A1 (en) | 2009-03-17 | 2022-01-26 | Nicox Ophthalmics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
US8569273B2 (en) | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP2664329A1 (de) * | 2012-05-15 | 2013-11-20 | F. Holzer GmbH | Ophthalmologisches Vehikelsystem |
US9409913B2 (en) * | 2012-11-21 | 2016-08-09 | Enaltec Labs Private Limited | Polymorphic forms of alcaftadine |
WO2014087208A2 (en) * | 2012-12-06 | 2014-06-12 | Enaltec Labs Pvt. Ltd. | A process of preparing alcaftadine |
CN109862851A (zh) | 2016-08-12 | 2019-06-07 | 蚕丝科技有限公司 | 用于治疗炎症的丝衍生蛋白质 |
WO2019022225A1 (ja) * | 2017-07-28 | 2019-01-31 | 参天製薬株式会社 | アルカフタジン又はその塩を含有する水性医薬組成物 |
JPWO2019026992A1 (ja) * | 2017-08-03 | 2020-06-18 | 参天製薬株式会社 | クロルヘキシジンを含有する医薬組成物 |
PT3740191T (pt) * | 2018-01-18 | 2021-07-09 | Faes Farma Sa | Composições oftálmicas compreendendo bilastina, uma beta-ciclodextrina e pelo menos um agente gelificante |
CA3181959A1 (en) | 2020-06-15 | 2021-12-23 | Alkem Laboratories Limited | Combination of alcaftadine and a corticosteroid |
JP2024508811A (ja) | 2021-02-24 | 2024-02-28 | オキュラ セラピューティクス,インコーポレイテッド | 小管内デポーインサータ装置 |
BR112023019795A2 (pt) | 2021-04-01 | 2023-11-07 | Alkem Laboratories Ltd | Composições nasais compreendendo alcaftadina |
TW202408468A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
WO2024010039A1 (ja) * | 2022-07-06 | 2024-01-11 | ロート製薬株式会社 | 眼科組成物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4148903A (en) | 1977-07-28 | 1979-04-10 | Merck & Co., Inc. | Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines |
DE3134672A1 (de) * | 1981-09-02 | 1983-03-17 | Boehringer Ingelheim KG, 6507 Ingelheim | Heterocyclische verbindungen, ihre herstellung und verwendung |
GB8900380D0 (en) | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
EP0552292B1 (en) | 1990-10-10 | 1995-06-21 | Schering Corporation | Substituted imidazobenzazepines and imidazopyridoazepines |
IT1248014B (it) * | 1991-06-07 | 1995-01-05 | Inverni Della Beffa Spa | Preparazioni oftalmiche a rilascio protratto |
IL101850A (en) * | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them |
US5641805A (en) | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
US20060100408A1 (en) * | 2002-03-11 | 2006-05-11 | Powell P M | Method for forming contact lenses comprising therapeutic agents |
US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
US20070077303A1 (en) | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for providing oxidatively stable ophthalmic compositions |
WO2007109523A2 (en) * | 2006-03-17 | 2007-09-27 | Johnson & Johnson Vision Care, Inc. | Stabilized ophthalmic compositions comprising oxidatively unstable components |
CA2648115C (en) | 2006-03-31 | 2015-03-24 | Vistakon Pharmaceuticals, Llc | Ocular allergy treatments |
-
2007
- 2007-03-26 CA CA2648115A patent/CA2648115C/en active Active
- 2007-03-26 PL PL16176695T patent/PL3150209T3/pl unknown
- 2007-03-26 KR KR1020087026545A patent/KR101321731B1/ko active IP Right Review Request
- 2007-03-26 NZ NZ571690A patent/NZ571690A/en unknown
- 2007-03-26 CN CN2012103679852A patent/CN102895234A/zh active Pending
- 2007-03-26 AU AU2007234957A patent/AU2007234957B2/en active Active
- 2007-03-26 EP EP07759365.5A patent/EP2004196B1/en active Active
- 2007-03-26 DK DK07759365.5T patent/DK2004196T3/en active
- 2007-03-26 SG SG201101394-3A patent/SG170044A1/en unknown
- 2007-03-26 BR BRPI0710085A patent/BRPI0710085B8/pt active IP Right Grant
- 2007-03-26 EA EA200870396A patent/EA016221B1/ru unknown
- 2007-03-26 WO PCT/US2007/064911 patent/WO2007117971A2/en active Application Filing
- 2007-03-26 EP EP16176695.1A patent/EP3150209B1/en active Active
- 2007-03-26 DK DK16176695T patent/DK3150209T3/da active
- 2007-03-26 US US11/690,954 patent/US8664215B2/en active Active
- 2007-03-26 MX MX2008012657A patent/MX2008012657A/es active IP Right Grant
- 2007-03-26 ES ES16176695T patent/ES2752823T3/es active Active
- 2007-03-26 PL PL07759365T patent/PL2004196T3/pl unknown
- 2007-03-26 ES ES07759365.5T patent/ES2594655T3/es active Active
- 2007-03-26 JP JP2009503195A patent/JP5292277B2/ja active Active
- 2007-03-30 TW TW096111374A patent/TWI450721B/zh active
- 2007-03-30 TW TW103115261A patent/TWI578990B/zh active
- 2007-04-01 JO JOP/2007/0103A patent/JO3358B1/ar active
- 2007-04-02 CL CL2007000916A patent/CL2007000916A1/es unknown
- 2007-04-02 UY UY30254A patent/UY30254A1/es not_active Application Discontinuation
- 2007-04-02 PE PE2007000398A patent/PE20080053A1/es active IP Right Grant
- 2007-04-03 AR ARP070101408A patent/AR060278A1/es not_active Application Discontinuation
-
2008
- 2008-09-30 NI NI200800261A patent/NI200800261A/es unknown
- 2008-09-30 MY MYPI20083927A patent/MY153669A/en unknown
- 2008-10-01 EC EC2008008786A patent/ECSP088786A/es unknown
- 2008-10-02 IL IL194473A patent/IL194473A/en active IP Right Grant
- 2008-10-29 NO NO20084593A patent/NO341147B1/no unknown
- 2008-10-30 ZA ZA2008/09327A patent/ZA200809327B/en unknown
- 2008-10-30 CR CR10414A patent/CR10414A/es unknown
-
2009
- 2009-10-15 HK HK09109552.2A patent/HK1131331A1/en unknown
-
2011
- 2011-02-04 US US13/020,961 patent/US20120094978A1/en not_active Abandoned
-
2013
- 2013-03-25 JP JP2013061939A patent/JP2013144703A/ja not_active Withdrawn
- 2013-10-08 US US14/049,078 patent/US20140107102A1/en not_active Abandoned
-
2015
- 2015-02-20 JP JP2015031395A patent/JP6039716B2/ja active Active
-
2016
- 2016-09-16 US US15/267,645 patent/US10617695B2/en active Active
-
2020
- 2020-03-11 US US16/815,967 patent/US20210030762A1/en not_active Abandoned
-
2022
- 2022-07-20 US US17/813,728 patent/US20230181594A1/en not_active Abandoned
-
2023
- 2023-02-28 US US18/175,787 patent/US20240058355A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO3358B1 (ar) | معالجات حساسية العيون | |
WO2008029276A3 (en) | Compositions and methods for the treatment of ophthalmic disease | |
WO2007092622A3 (en) | Compositions and methods for treating bone | |
WO2009044173A3 (en) | Methods of treating cancer using notch pathway inhibitors | |
MX2009009207A (es) | Metodos y composiciones para normalizar las secreciones de glandulas meibomianas. | |
WO2006091459A3 (en) | Compositions and methods for treating vascular permeability | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
EA200901486A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
TNSN08400A1 (en) | Organic compounds and their uses | |
MY149606A (en) | Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment | |
MX349787B (es) | Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido. | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
MA32934B1 (ar) | تركيبات مضادة ل hsp90 | |
EA201170521A1 (ru) | Новые соединения | |
MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
IN2012DN00624A (ar) | ||
WO2007084684A3 (en) | Therapeutic uses of inhibitors of rtp801 | |
MX2009005725A (es) | Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13. | |
EP2069377A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS | |
WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
EA200901484A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
WO2009136997A3 (en) | Inhibitors of human cathepsin l, cathepsin b, and cathepsin s | |
HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
AR111697A2 (es) | Composición oftálmica para el tratamiento de las alergias oculares |